While the company’s sales outlook was otherwise rosy, Merck took sales hits on Gardisil, Proquad, Varivax and Vaxneuvance.

With vaccine sales on the decline, these are tough times for Merck to launch its new pneumococcal shot Capvaxive. | With ...

If you miss the October vaccination window, there is still plenty of time to get protected before Thanksgiving. With ...

Pneumococcal disease poses a severe risk to Indian adults, particularly those with chronic health issues. Despite effective vaccines, awareness and up ...